Financial News
Cognex Reports Record Quarterly Revenue
Cognex Corporation (NASDAQ: CGNX) today reported financial results for the second quarter of 2021. Cognex announced the highest quarterly revenue in the company’s 40-year history and new records for second quarter revenue, net income, and net income per diluted share. Table 1 below shows selected financial data for Q2-21 compared with Q2-20 and Q1-21, and for the six months of 2021 compared with the same period in 2020.
Table 1 |
||||
(Dollars in thousands, except per share amounts) |
||||
|
Revenue |
Net Income/(Loss) |
Net Income/(Loss) per Diluted Share |
Non-GAAP Net Income per Diluted Share* |
Quarterly Comparisons |
||||
Current quarter: Q2-21 |
$269,158 |
$77,598 |
$0.43 |
$0.43 |
Prior year’s quarter: Q2-20 |
$169,097 |
$(1,142) |
$(0.01) |
$0.18 |
Change: Q2-20 to Q2-21 |
59% |
N/M |
N/M |
139% |
Prior quarter: Q1-21 |
$239,027 |
$69,848 |
$0.39 |
$0.36 |
Change: Q1-21 to Q2-21 |
13% |
11% |
10% |
19% |
Year-to-Date Comparisons |
||||
Six months ended July 4, 2021 |
$508,185 |
$147,446 |
$0.82 |
$0.79 |
Six months ended June 28, 2020 |
$336,332 |
$19,335 |
$0.11 |
$0.29 |
Change from first six months of 2020 to first six months of 2021 |
51% |
663% |
645% |
172% |
*Non-GAAP net income per diluted share excludes restructuring and other charges and discrete tax adjustments. Notably, Cognex recorded charges totaling over $42 million in Q2-20 that reduced earnings for the quarter by $0.19 per diluted share. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.
“What a quarter!” said Robert J. Willett, Chief Executive Officer of Cognex. “Revenue was the highest in our company’s 40-year history and grew substantially year over year due to strong, broad-based demand for Cognex products. We were also highly profitable and reported an operating margin of 34%, which is well above our 30% long-term target.”
Mr. Willett continued, “We are excited about the growth opportunities we see for our company, and we are managing well so far through a difficult supply environment. Even so, we expect the revenue growth rate will moderate in the second half, particularly in Q3, because of the substantial increase in revenue we reported last year from the consumer electronics industry.”
Details of the Quarter
Statement of Operations Highlights – Second Quarter of 2021
- Cognex reported record revenue of $269 million for the second quarter, which represents an increase of 59% from Q2-20 and 13% from Q1-21. Revenue from each geographic region (the Americas, Asia, and Europe) grew substantially from Q2-20, which was marked by significant economic disruption following the COVID-19 outbreak. The largest end-market contributions in absolute dollars came from logistics, which set another quarterly revenue record, and the automotive industry. Consumer electronics also increased substantially both year-on-year and sequentially, helped by revenue that we had expected to recognize in the second half of 2021.
- Gross margin was 75% for Q2-21, 70% for Q2-20, and 77% for Q1-21. The increase in gross margin year-on-year is due to a pre-tax charge of $8 million in Q2-20 for the write-down of excess and obsolete inventories resulting from the difficult business conditions Cognex was experiencing in many of its markets.
- Research, Development, & Engineering (RD&E) expenses increased by 3% from Q2-20 and decreased 8% from Q1-21. RD&E spending increased year-on-year due to the impact of foreign currency exchange rates on the company’s international operations. Higher incentive compensation costs and stock-based compensation expense were offset by savings from the company’s actions in 2020 to reduce expenses (discussed below). RD&E spending decreased on a sequential basis due to the timing of application engineering for large revenue opportunities.
- Selling, General & Administrative (SG&A) expenses increased by 28% from Q2-20 and 6% from Q1-21. SG&A spending increased year-on-year due to higher incentive compensation costs (including sales commissions and the bonus accrual), stock-based compensation expense, travel, and sales and marketing activities and the impact of foreign currency exchange rate changes. SG&A spending increased on a sequential basis due to higher sales commissions, travel, and internal equipment.
- Notable in Q2-20, Cognex recorded a pre-tax charge of $15 million for restructuring actions announced by the company on May 28, 2020, and a pre-tax charge of $20 million for the impairment of acquired intangible assets resulting from deteriorated market conditions a year ago.
- The effective tax rate in Q2-21 was an expense of 17% compared with a benefit of 51% in Q2-20 and an expense of 11% in Q1-21. Excluding the discrete tax adjustments summarized in Exhibit 2, the effective tax rate was an expense of 18% in both Q2-21 and Q1-21 compared to a benefit of 1% in Q2-20.
Balance Sheet Highlights – July 4, 2021
- Cognex’s financial position as of July 4, 2021 continued to be strong, with $952 million in cash and investments and no debt. In the first six months of 2021, Cognex generated $195 million in cash from operations and $44 million in net proceeds from the exercise of stock options. In addition, the company paid $21 million in dividends to shareholders and spent $21 million to repurchase its common stock. Cognex intends to continue to repurchase shares of its common stock pursuant to its existing stock repurchase program, subject to market conditions and other relevant factors.
Financial Outlook – Q3 2021
- Cognex believes revenue in Q3-21 will be between $275 million and $295 million. This range represents growth over both Q3-20 and Q2-21 due to higher expected revenue from logistics, automotive, and the broader factory automation market. The growth rate in Q3-21 is expected to moderate as compared to the first half of 2021 because of consumer electronics. Cognex believes consumer electronics revenue will be more evenly split between Q2 and Q3 in 2021 than in 2020 (when the majority was recognized in Q3) and that consumer electronics revenue will decline modestly for the year.
- Gross margin for Q3-21 is expected to be in the low-to-mid 70% range, and lower than the gross margin reported for Q2-21, due to the company’s support of a high-potential customer in logistics and higher supply chain costs.
- Operating expenses are expected to be up by mid-single digits from Q2-21 due to investments in engineering and sales, support of large deployments of Cognex products and upcoming product launches, and increased sales activities.
- The effective tax rate is expected to be 18%, excluding discrete tax items.
Non-GAAP Financial Measures
- Exhibit 2 of this news release includes a reconciliation of certain financial measures from GAAP to non-GAAP. Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare Cognex results over multiple periods using the same methodology that management employs in its budgeting process and in its review of Cognex’s operating results. Non-GAAP presentations exclude certain one-time discrete events, such as discrete tax adjustments (because these costs are outside of Cognex’s normal business operations and not used by management to assess Cognex’s operating results). Additionally, the company excludes restructuring charges, intangible asset impairment charges, and excess and obsolete inventory charges because these charges result from discrete activities, such as specific restructuring actions or acquisitions, that management frequently excludes in evaluating Cognex’s operating results. Cognex does not intend for non-GAAP financial measures to be considered in isolation, or as a substitute for financial information provided in accordance with GAAP.
- We estimate the tax effect of items identified in the reconciliation by applying the effective tax rate to the pre-tax amount. However, if a specific tax rate or tax treatment is required because of the nature of the item and/or the tax jurisdiction where the item was recorded, we estimate the tax effect by applying the relevant specific tax rate or tax treatment, rather than the effective tax rate.
Analyst Conference Call and Simultaneous Webcast
- Cognex will host a conference call today at 5:00 p.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 (or (201) 389-0911 if outside the United States). A replay will begin at 8:00 p.m. EDT today and will be available until 11:59 p.m. EDT on Sunday, August 8, 2021. The telephone number for the replay is (877) 660-6853 (or (201) 612-7415 if outside the United States). The access code for both the live call and the replay is 13720531.
- A real-time audio broadcast of the conference call or an archived recording will be accessible on the Events & Presentations page of the Cognex Investor website: https://www.cognex.com/Investor.
About Cognex Corporation
Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors, and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.
Cognex is the world's leader in the machine vision industry, having shipped more than 3 million image-based products, representing over $8 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe, and Asia. For details, visit Cognex online at www.cognex.com.
Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These statements are based on our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements—which include statements regarding business and market trends; future financial performance; growth opportunities; the expected impact of the COVID-19 pandemic on our assets, business and results of operations; managing supply constraints; customer order rates and timing of related revenue; future product mix; restructuring and other cost-savings initiatives; research and development activities; sales and marketing activities; investments; liquidity; dividends and stock repurchases; strategic plans; and estimated tax benefits and expenses and other tax matters—involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the impact, duration, and severity of the COVID-19 pandemic; (2) potential disruptions to our business due to restructuring activities; (3) the loss of, or curtailment of purchases by, large customers in the consumer electronics and logistics industries; (4) the reliance on revenue from the automotive industry; (5) the reliance on key suppliers to manufacture and deliver critical components for our products and potential disruptions in the supply chain, which could impact timely delivery of customer orders; (6) the failure to effectively manage product transitions or accurately forecast customer demand; (7) the inability to design and manufacture high-quality products; (8) the inability to attract and retain skilled employees and maintain our unique corporate culture; (9) the failure to effectively manage our growth; (10) the inability to achieve growth in revenue and profits from the logistics industry; (11) the technological obsolescence of current products and the inability to develop new products; (12) the failure to properly manage the distribution of products and services; (13) the impact of competitive pressures; (14) the challenges in integrating and achieving expected results from acquired businesses; (15) potential disruptions in our business systems; (16) information security breaches; (17) the inability to protect our proprietary technology and intellectual property; (18) potential impairment charges with respect to our investments or acquired intangible assets; (19) exposure to additional tax liabilities; (20) fluctuations in foreign currency exchange rates and the use of derivative instruments; (21) our involvement in time-consuming and costly litigation; (22) unfavorable global economic conditions; (23) economic, political, and other risks associated with international sales and operations; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2020 and Form 10-Q for the fiscal quarter ended July 4, 2021. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.
Exhibit 1
COGNEX CORPORATION |
||||||||||||||||||||
Statements of Operations |
||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||
Dollars in thousands, except per share amounts |
||||||||||||||||||||
|
Three-months Ended |
|
Six-months Ended |
|||||||||||||||||
|
July 4,
|
|
April 4,
|
|
June 28,
|
|
July 4,
|
|
June 28,
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Revenue |
$ |
269,158 |
|
|
$ |
239,027 |
|
|
$ |
169,097 |
|
|
$ |
508,185 |
|
|
$ |
336,332 |
|
|
Cost of revenue (1) |
68,432 |
|
|
54,045 |
|
|
50,320 |
|
|
122,477 |
|
|
91,520 |
|
||||||
Gross margin |
200,726 |
|
|
184,982 |
|
|
118,777 |
|
|
385,708 |
|
|
244,812 |
|
||||||
Percentage of revenue |
75 |
% |
|
77 |
% |
|
70 |
% |
|
76 |
% |
|
73 |
% |
||||||
Research, development, and engineering expenses (1) |
31,302 |
|
|
34,105 |
|
|
30,397 |
|
|
65,407 |
|
|
66,343 |
|
||||||
Percentage of revenue |
12 |
% |
|
14 |
% |
|
18 |
% |
|
13 |
% |
|
20 |
% |
||||||
Selling, general, and administrative expenses (1) |
76,843 |
|
|
72,424 |
|
|
60,153 |
|
|
149,267 |
|
|
129,291 |
|
||||||
Percentage of revenue |
29 |
% |
|
30 |
% |
|
36 |
% |
|
29 |
% |
|
38 |
% |
||||||
Restructuring charges |
— |
|
|
— |
|
|
14,798 |
|
|
— |
|
|
14,798 |
|
||||||
Intangible asset impairment charges |
— |
|
|
— |
|
|
19,571 |
|
|
— |
|
|
19,571 |
|
||||||
Operating income (loss) |
92,581 |
|
|
78,453 |
|
|
(6,142 |
) |
|
171,034 |
|
|
14,809 |
|
||||||
Percentage of revenue |
34 |
% |
|
33 |
% |
|
(4 |
)% |
|
34 |
% |
|
4 |
% |
||||||
Foreign currency gain (loss) |
(639 |
) |
|
(1,008 |
) |
|
336 |
|
|
(1,647 |
) |
|
(2,667 |
) |
||||||
Investment and other income |
1,596 |
|
|
1,386 |
|
|
3,494 |
|
|
2,982 |
|
|
8,540 |
|
||||||
Income (loss) before income tax expense (benefit) |
93,538 |
|
|
78,831 |
|
|
(2,312 |
) |
|
172,369 |
|
|
20,682 |
|
||||||
Income tax expense (benefit) |
15,940 |
|
|
8,983 |
|
|
(1,170 |
) |
|
24,923 |
|
|
1,347 |
|
||||||
Net income (loss) |
$ |
77,598 |
|
|
$ |
69,848 |
|
|
$ |
(1,142 |
) |
|
$ |
147,446 |
|
|
$ |
19,335 |
|
|
Percentage of revenue |
29 |
% |
|
29 |
% |
|
(1 |
)% |
|
29 |
% |
|
6 |
% |
||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income (loss) per weighted-average common and common-equivalent share: |
|
|
|
|
|
|
|
|
|
|||||||||||
Basic |
$ |
0.44 |
|
|
$ |
0.40 |
|
|
$ |
(0.01 |
) |
|
$ |
0.84 |
|
|
$ |
0.11 |
|
|
Diluted |
$ |
0.43 |
|
|
$ |
0.39 |
|
|
$ |
(0.01 |
) |
|
$ |
0.82 |
|
|
$ |
0.11 |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted-average common and common-equivalent shares outstanding: |
|
|
|
|
|
|
|
|
|
|||||||||||
Basic |
176,626 |
|
|
176,288 |
|
|
172,283 |
|
|
176,454 |
|
|
172,345 |
|
||||||
Diluted |
179,991 |
|
|
179,971 |
|
|
172,283 |
|
|
179,982 |
|
|
175,499 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash dividends per common share |
$ |
0.060 |
|
|
$ |
0.060 |
|
|
$ |
0.055 |
|
|
$ |
0.120 |
|
|
$ |
0.110 |
|
|
Cash and investments per common share |
$ |
5.39 |
|
|
$ |
4.96 |
|
|
$ |
5.18 |
|
|
$ |
5.39 |
|
|
$ |
5.18 |
|
|
Book value per common share |
$ |
8.09 |
|
|
$ |
7.68 |
|
|
$ |
7.95 |
|
|
$ |
8.09 |
|
|
$ |
7.95 |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
(1) Amounts include stock-based compensation expense, as follows: |
|
|
|
|
|
|
|
|
|
|||||||||||
Cost of revenue |
$ |
351 |
|
|
$ |
248 |
|
|
$ |
363 |
|
|
$ |
599 |
|
|
$ |
717 |
|
|
Research, development, and engineering |
3,064 |
|
|
4,003 |
|
|
2,401 |
|
|
7,067 |
|
|
7,767 |
|
||||||
Selling, general, and administrative |
7,315 |
|
|
7,758 |
|
|
5,254 |
|
|
15,073 |
|
|
14,324 |
|
||||||
Total stock-based compensation expense |
$ |
10,730 |
|
|
$ |
12,009 |
|
|
$ |
8,018 |
|
|
$ |
22,739 |
|
|
$ |
22,808 |
|
|
Exhibit 2
COGNEX CORPORATION |
|||||||||||||||||||||
Reconciliation of Selected Items from GAAP to Non-GAAP |
|||||||||||||||||||||
(Unaudited) |
|||||||||||||||||||||
Dollars in thousands, except per share amounts |
|||||||||||||||||||||
|
Three-months Ended |
|
|
Six-months Ended |
|||||||||||||||||
|
July 4,
|
|
April 4,
|
|
June 28,
|
|
|
July 4,
|
|
June 28,
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Discrete tax adjustments reconciliation |
|
|
|
|
|
|
|
||||||||||||||
Income (loss) before income tax expense (benefit) (GAAP) |
$ |
93,538 |
|
|
$ |
78,831 |
|
|
$ |
(2,312 |
) |
|
|
$ |
172,369 |
|
|
$ |
20,682 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income tax expense (benefit) (GAAP) |
$ |
15,940 |
|
|
$ |
8,983 |
|
|
$ |
(1,170 |
) |
|
|
$ |
24,923 |
|
|
$ |
1,347 |
|
|
Effective tax rate (GAAP) |
17 |
% |
|
11 |
% |
|
(51 |
)% |
|
|
14 |
% |
|
7 |
% |
||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Discrete tax benefit related to stock-based compensation |
1,431 |
|
|
5,207 |
|
|
4,413 |
|
|
|
6,638 |
|
|
6,093 |
|
||||||
Discrete tax expense related to tax return filings and other |
(535 |
) |
|
— |
|
|
(3,267 |
) |
|
|
(535 |
) |
|
(3,509 |
) |
||||||
Total discrete tax adjustments |
$ |
896 |
|
|
$ |
5,207 |
|
|
$ |
1,146 |
|
|
|
$ |
6,103 |
|
|
$ |
2,584 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Income tax expense (benefit) (Non-GAAP) |
$ |
16,836 |
|
|
$ |
14,190 |
|
|
$ |
(24 |
) |
|
|
$ |
31,026 |
|
|
$ |
3,931 |
|
|
Effective tax rate (Non-GAAP) |
18 |
% |
|
18 |
% |
|
(1 |
)% |
|
|
18 |
% |
|
19 |
% |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring and other charges and discrete tax adjustments reconciliation |
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income (loss) (GAAP) |
$ |
77,598 |
|
|
$ |
69,848 |
|
|
$ |
(1,142 |
) |
|
|
$ |
147,446 |
|
|
$ |
19,335 |
|
|
Excess and obsolete inventory charges |
1,111 |
|
|
705 |
|
|
7,718 |
|
|
|
1,816 |
|
|
8,783 |
|
||||||
Restructuring charges |
— |
|
|
— |
|
|
14,798 |
|
|
|
— |
|
|
14,798 |
|
||||||
Intangible asset impairment charges |
— |
|
|
— |
|
|
19,571 |
|
|
|
— |
|
|
19,571 |
|
||||||
Tax effect on restructuring and other charges |
(200 |
) |
|
(127 |
) |
|
(7,997 |
) |
|
|
(327 |
) |
|
(8,199 |
) |
||||||
Discrete tax adjustments |
(896 |
) |
|
(5,207 |
) |
|
(1,146 |
) |
|
|
(6,103 |
) |
|
(2,584 |
) |
||||||
Net income (Non-GAAP) |
$ |
77,613 |
|
|
$ |
65,219 |
|
|
$ |
31,802 |
|
|
|
$ |
142,832 |
|
|
$ |
51,704 |
|
|
Percentage of revenue (Non-GAAP) |
29 |
% |
|
27 |
% |
|
19 |
% |
|
|
28 |
% |
|
15 |
% |
||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP) |
$ |
0.43 |
|
|
$ |
0.39 |
|
|
$ |
(0.01 |
) |
|
|
$ |
0.82 |
|
|
$ |
0.11 |
|
|
Per share impact of non-GAAP adjustments identified above |
— |
|
|
(0.03 |
) |
|
0.19 |
|
|
|
(0.03 |
) |
|
0.18 |
|
||||||
Net income per diluted weighted-average common and common-equivalent share (Non-GAAP) |
$ |
0.43 |
|
|
$ |
0.36 |
|
|
$ |
0.18 |
|
|
|
$ |
0.79 |
|
|
$ |
0.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP) |
179,991 |
|
|
179,971 |
|
|
175,403 |
|
|
|
179,982 |
|
|
175,499 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
Exhibit 3
COGNEX CORPORATION |
||||||||
Balance Sheets |
||||||||
(Unaudited) |
||||||||
Dollars in thousands |
||||||||
|
July 4, 2021 |
|
December 31, 2020 |
|||||
Assets |
|
|
|
|||||
Cash and investments |
$ |
951,749 |
|
|
$ |
767,438 |
|
|
Accounts receivable |
149,157 |
|
|
125,696 |
|
|||
Inventories |
68,503 |
|
|
60,830 |
|
|||
Property, plant, and equipment |
76,972 |
|
|
79,173 |
|
|||
Operating lease assets |
21,277 |
|
|
22,582 |
|
|||
Goodwill and intangible assets |
256,608 |
|
|
259,633 |
|
|||
Deferred tax assets |
425,618 |
|
|
434,704 |
|
|||
Other assets |
75,037 |
|
|
50,646 |
|
|||
|
|
|
|
|||||
Total assets |
$ |
2,024,921 |
|
|
$ |
1,800,702 |
|
|
|
|
|
|
|||||
Liabilities and Shareholders' Equity |
|
|
|
|||||
Accounts payable and accrued expenses |
$ |
108,957 |
|
|
$ |
93,534 |
|
|
Deferred revenue and customer deposits |
76,445 |
|
|
21,274 |
|
|||
Operating lease liabilities |
24,250 |
|
|
26,230 |
|
|||
Income taxes |
67,834 |
|
|
72,551 |
|
|||
Deferred tax liabilities |
306,355 |
|
|
314,952 |
|
|||
Other liabilities |
11,626 |
|
|
9,959 |
|
|||
Shareholders' equity |
1,429,454 |
|
|
1,262,202 |
|
|||
|
|
|
|
|||||
Total liabilities and shareholders' equity |
$ |
2,024,921 |
|
|
$ |
1,800,702 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210805006044/en/
Contacts
Susan Conway
Investor Relations
+1 508-650-3353
Susan.conway@cognex.com
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.